Premium
NONSTEROID ANTI‐INFLAMMATORY AGENTS IN THE THERAPY OF RHEUMATIC DISEASES
Author(s) -
WARD L. EMMERSON
Publication year - 1968
Publication title -
journal of the american geriatrics society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.992
H-Index - 232
eISSN - 1532-5415
pISSN - 0002-8614
DOI - 10.1111/j.1532-5415.1968.tb02091.x
Subject(s) - medicine , rheumatoid arthritis , phenylbutazone , intensive care medicine , gold salts , rheumatic disease , disease , antirheumatic drugs , physical therapy , antirheumatic agents
A bstract : The management of rheumatoid arthritis is outlined in detail since certain basic principles are applicable to the management of other rheumatic disorders discussed much more briefly. Emphasis is laid on the physician‐patient relationship. It is important for the physician to inform the patient of some of the basic facts about the disease and the general objectives of treatment. Also important is the patient's choice of objectives. Therapy with the following nonsteroid drugs is discussed: salicylates, indomethacin, phenylbutazone, aminoquinoline compounds and gold salts. The treatment of rheumatic diseases is largely empiric and is directed toward symptomatic relief and palliation. Knowledge of causes and cure is grossly deficient, and our therapeutic capabilities are limited. Nevertheless, significant advances are being made in the investigative laboratories and in the application to patients of the knowledge and therapy which are available.